Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Damkier

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Scandinavian Journal of Public Health|July 8, 2022
Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptakeMette Reilev, Morten Olesen, Helene Kildegaard, et al.
Therapeutic Advances in Gastroenterology|December 6, 2017
Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control studyMette Reilev, Per Damkier, Lotte Rasmussen, et al.
BMJ Open|August 3, 2018
Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in DenmarkLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or FlucloxacillinMaja Hellfritzsch, Lars Christian Lund, Zandra Ennis, et al.
Basic & Clinical Pharmacology & Toxicology|October 2, 2021
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patientsIda Kuhlmann, Rasmus Hjelmar Petersen, Morten Overgaard, et al.
The Oncologist|January 25, 2015
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human useKyriaki Tzogani, Venke Skibeli, Ingunn Westgaard, et al.
Obstetrics and Gynecology|April 17, 2025
In ReplyPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Paediatric and Perinatal Epidemiology|September 11, 2025
Psychotropic Medication Exposure via Breast Milk: A Population-Based Descriptive Study in DenmarkXiaoqin Liu, Kathrine Bang Madsen, Jin Liang Zhu, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Scandinavian Journal of Public Health|July 8, 2022
Changing characteristics over time of individuals receiving COVID-19 vaccines in Denmark: A population-based descriptive study of vaccine uptakeMette Reilev, Morten Olesen, Helene Kildegaard, et al.
Therapeutic Advances in Gastroenterology|December 6, 2017
Use of beta-blockers and risk of serious upper gastrointestinal bleeding: a population-based case-control studyMette Reilev, Per Damkier, Lotte Rasmussen, et al.
BMJ Open|August 3, 2018
Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in DenmarkLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or FlucloxacillinMaja Hellfritzsch, Lars Christian Lund, Zandra Ennis, et al.
Basic & Clinical Pharmacology & Toxicology|October 2, 2021
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patientsIda Kuhlmann, Rasmus Hjelmar Petersen, Morten Overgaard, et al.
The Oncologist|January 25, 2015
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human useKyriaki Tzogani, Venke Skibeli, Ingunn Westgaard, et al.
Obstetrics and Gynecology|April 17, 2025
In ReplyPer Damkier, Erika B Gram, Michael Ceulemans, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Paediatric and Perinatal Epidemiology|September 11, 2025
Psychotropic Medication Exposure via Breast Milk: A Population-Based Descriptive Study in DenmarkXiaoqin Liu, Kathrine Bang Madsen, Jin Liang Zhu, et al.
Pageof 21